Antimicrobial activity and mechanism of anti-MRSA of phloroglucinol derivatives
Authors:
- 22 January 2024
- journal article
- research article
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 32 (1) , 177-187
Abstract
Background In previous studies, authors have completed the total synthesis of several phloroglucinol natural products and synthesized a series of their derivatives, which were tested with good biological activities. Objectives To discover anti-MRSA lead compound and study their mechanism of action. Methods Phloroglucinol derivatives were tested to investigate their activities against several gram-positive strains including Methicillin-resistant Staphylococcus aureus (MRSA). The mechanism study was conducted by determining extracellular potassium ion concentration, intracellular NADPH oxidase content, SOD activity, ROS amount in MRSA and MRSA survival rate under A5 treatment. The in vitro cytotoxicity test of A5 was conducted. Results The activity of monocyclic compounds was stronger than that of bicyclic compounds, and compound A5 showed the best MIC value of 0.98 μg/mL and MBC value of 1.95 μg/mL, which were 4–8 times lower than that of vancomycin. The mechanism study of A5 showed that it achieved anti-MRSA effect through membrane damage, which is proved by increased concentration of extracellular potassium ion after A5 treatment. Another possible mechanism is the over ROS production induced cell death, which is suggested by observed alternation of several reactive oxygen species (ROS) related indicators including NADPH concentration, superoxide dismutase (SOD) activity, ROS content and bacterial survival rate after A5 treatment. The cytotoxicity results in vitro showed that A5 was basically non-toxic to cells. Conclusion Acylphloroglucinol derivative A5 showed good anti-MRSA activity, possibly via membrane damage and ROS-mediated oxidative stress mechanism. It deserves further exploration to be a potential lead for the development of new anti-MRSA agent. Graphical AbstractKeywords
This publication has 31 references indexed in Scilit:
- Investigation of antibacterial activity of aspidin BB against Propionibacterium acnesArchives of Dermatological Research, 2015
- Mechanisms of Methicillin Resistance in Staphylococcus aureusAnnual Review of Biochemistry, 2015
- Synthesis, Structure–Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin A and DerivativesJournal of Medicinal Chemistry, 2014
- Aspidin BB, a phloroglucinol derivative, exerts its antibacterial activity against Staphylococcus aureus by inducing the generation of reactive oxygen speciesResearch in Microbiology, 2014
- A novel study of antibacterial activity of copper iodide nanoparticle mediated by DNA and membrane damageColloids and Surfaces B: Biointerfaces, 2012
- Management of bacterial infections in cirrhosisJournal of Hepatology, 2012
- In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA)International Journal of Antimicrobial Agents, 2006
- Natural Products and Antifungal Drug Discovery2004
- Studies on the Antioxidative Activity of Phloroglucinol Derivatives Isolated fromHypericumSpeciesPlanta Medica, 2003
- The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen speciesProceedings of the National Academy of Sciences, 2001